Aspen Aerogels stock targets positive EBITDA in Q3 guidance

Published on 10/04/2026 at 14:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aspen Aerogels stock was last at USD 5.69 on October 2, 2026, while Q2 revenue reached USD 49.8 million. Q3 guidance calls for USD 7 million to USD 15 million in adjusted EBITDA.

ASPN, US04523Y1055, Illustration mit AI erstellt.

Aspen Aerogels stock (ISIN US04523Y1055) was last at USD 5.69 on the NYSE on October 2, 2026, up 2.34 percent from the prior close. The company is heading into its next results date with guidance for a return to positive adjusted EBITDA, while its latest investor presentation outlined capacity and cash priorities.

Positive EBITDA enters the forecast

In its investor presentation dated September 15, 2026, Aspen Aerogels said its last-twelve-month revenue through Q2 2026 was USD 202 million and that its manufacturing and supply network supports annual revenue capacity above USD 600 million. The presentation also set long-term targets of a 35 percent gross margin and a 25 percent adjusted EBITDA margin.

The near-term hurdle is execution. StockTitan reported that Aspen guided for Q3 2026 revenue of USD 65 million to USD 80 million, a net loss of USD 6 million to USD 9 million and adjusted EBITDA of USD 7 million to USD 15 million. The guidance is therefore positive on adjusted EBITDA while still forecasting a GAAP loss.

Q2 revenue improved sequentially

Aspen's Q2 2026 revenue was USD 49.8 million, up 32 percent from Q1, according to StockTitan. The quarter still produced a net loss of USD 23.3 million, compared with USD 9.1 million in the year-earlier quarter, showing why the adjusted EBITDA target matters more than revenue growth alone.

The company said Q2 revenue was USD 49.8 million versus USD 78.0 million a year earlier, while Thermal Barrier revenue was USD 29.5 million and Energy Industrial revenue was USD 20.4 million. The year-over-year decline keeps the recovery dependent on demand in electric-vehicle thermal barriers and execution in energy industrial projects.

Consensus sits near the market price

MarketBeat reported a Hold consensus from seven analysts and an average 12-month target of USD 5.94. That target lies 4.39 percent above the October 2 price of USD 5.69, while the published analyst mix included four Buy ratings, one Hold rating and two Sell ratings.

Stock stays below its yearly high

ASPN had a market capitalization of USD 471.6 million and volume of 838,901 shares on October 2, 2026. Its USD 5.69 price was 39.14 percent below the 52-week high of USD 9.35 and above the 52-week low of USD 2.30.

Investing.com lists October 22, 2026 as Aspen Aerogels' next earnings date. The report will test whether the projected adjusted EBITDA improvement can arrive alongside the guided revenue range.